Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China flag China · Delayed Price · Currency is CNY
4.430
+0.010 (0.23%)
Feb 4, 2026, 1:25 PM CST

SHE:300194 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
982.87846.31991.84688.53981.13853.39
Trading Asset Securities
80.01305.0515.2120.8675.67
Cash & Short-Term Investments
1,063876.32996.89703.741,002929.05
Cash Growth
9.68%-12.10%41.66%-29.77%7.85%7.83%
Accounts Receivable
243.4255.39359.39433.24393.02370.1
Other Receivables
6.9231.3123.818.9219.6617.89
Receivables
250.32286.71383.19452.16412.68387.98
Inventory
680.99850.97707.8719.75631.92590.17
Prepaid Expenses
-----0.34
Other Current Assets
63.0151.738.3651.4238.641.76
Total Current Assets
2,0572,0662,1261,9272,0851,949
Property, Plant & Equipment
1,7061,7671,7361,6961,4461,222
Long-Term Investments
1,2641,2161,1831,072752.43699.42
Goodwill
261.18261.18261.18485.69508.66709.72
Other Intangible Assets
426.17441.2401.71383.81382.371,015
Long-Term Deferred Tax Assets
70.1560.5465.81101.8649.1540.16
Long-Term Deferred Charges
111.35105.37138.52176.2170.25135.89
Other Long-Term Assets
71.4461.663.3735.35312.58201.07
Total Assets
5,9675,9795,9765,8785,7065,973
Accounts Payable
283.4436.39379.48385.07289.77216.04
Accrued Expenses
24.14116.73225.43253.93232.76225.46
Short-Term Debt
459.77333.32349.11406.34642.15477.5
Current Portion of Long-Term Debt
15.01177.3254.062.51--
Current Portion of Leases
-1.110.980.58-19.91
Current Income Taxes Payable
25.944.4615.526.62912.46
Current Unearned Revenue
26.354.0951.2561.9657.1556.21
Other Current Liabilities
109.13103.58119.22170.0457.6653.95
Total Current Liabilities
943.691,2271,1951,2871,2881,062
Long-Term Debt
420.7193.54487.14303.7263.88124.21
Long-Term Leases
0.080.491.571.06--
Long-Term Unearned Revenue
101.38109.9192.3698.0675.0353.09
Long-Term Deferred Tax Liabilities
47.3149.551.0964.3535.9231.64
Other Long-Term Liabilities
0.010.010.01177.27177.27147.25
Total Liabilities
1,5131,5801,8271,9321,8411,418
Common Stock
1,1901,1901,1901,1901,1901,190
Additional Paid-In Capital
2,2372,2372,2372,2272,2272,231
Retained Earnings
1,035952.26731.91559.53354.92711.32
Comprehensive Income & Other
-9.7516.74-13.98-31.58-37.96-31.74
Total Common Equity
4,4524,3964,1453,9453,7344,100
Minority Interest
1.862.253.921.38131.75454.87
Shareholders' Equity
4,4544,3984,1493,9463,8664,555
Total Liabilities & Equity
5,9675,9795,9765,8785,7065,973
Total Debt
895.57705.78892.86714.2906.03621.62
Net Cash (Debt)
167.31170.54104.03-10.4595.96307.43
Net Cash Growth
-35.11%63.93%---68.79%-58.79%
Net Cash Per Share
0.150.150.09-0.010.080.26
Filing Date Shares Outstanding
1,1901,1901,1901,1901,1901,190
Total Common Shares Outstanding
1,1901,1901,1901,1901,1901,190
Working Capital
1,113838.7931.19640.01796.7887.77
Book Value Per Share
3.743.693.483.323.143.45
Tangible Book Value
3,7653,6933,4823,0762,8432,376
Tangible Book Value Per Share
3.163.102.932.592.392.00
Buildings
-1,2461,191875.88871.16724.77
Machinery
-1,7651,6151,3471,2251,072
Construction In Progress
-114.23155.84695.25441.2427.73
Source: S&P Global Market Intelligence. Standard template. Financial Sources.